Photo
Corps éditorial
Biographie
Helena Huerga est docteure en médecine et titulaire d'un master en épidémiologie. Elle possède une longue expérience professionnelle dans le domaine humanitaire. Elle dirige des études de recherche opérationnelle axées sur les maladies infectieuses, avec un intérêt particulier pour la tuberculose.
Ses publications
COVID-19, tuberculosis, and HIV triad: a prospective observational study in ambulatory patients in Kenya, Uganda, and South Africa.
Référence de l'article:
PLOS global public health 2025 ; 5(4); . doi: 10.1371/journal.pgph.0004471. Epub 2025 04 23
Adolescents and young adults are the most undiagnosed of HIV and virally unsuppressed in Eastern and Southern Africa: Pooled analyses from five population-based surveys.
Référence de l'article:
PLOS global public health 2023 ; 3(12); . doi: 10.1371/journal.pgph.0002398. Epub 2023 12 22
Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective.
Référence de l'article:
PLOS global public health 2023 ; 3(4); . doi: 10.1371/journal.pgph.0000818. Epub 2023 04 28
Evidence of HIV incidence reduction in young women, but not in adolescent girls, in KwaZulu-Natal, South Africa.
Référence de l'article:
IJID regions 2023 Sep ; 8; . doi: 10.1016/j.ijregi.2023.07.004. Epub 2023 07 13
Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study.
Référence de l'article:
The Lancet. Global health 2023 Jan ; 11(1); . doi: 10.1016/S2214-109X(22)00463-6. Epub 2022 12 19
Lots of considerations when evaluating the FujiLAM assay - Author's reply.
Référence de l'article:
The Lancet. Global health 2023 Apr ; 11(4); . doi: 10.1016/S2214-109X(23)00115-8. Epub 2023 03 16
Increase in HIV viral suppression in KwaZulu-Natal, South Africa: Community-based cross sectional surveys 2018 and 2013. What remains to be done?
Référence de l'article:
PloS one 2022 ; 17(3); . doi: 10.1371/journal.pone.0265488. Epub 2022 03 24
Safety and effectiveness outcomes from a 14-country cohort of patients with multi-drug resistant tuberculosis treated concomitantly with bedaquiline, delamanid and other second-line drugs.
Référence de l'article:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Mar 04; doi: 10.1093/cid/ciac176. Epub 2022 03 04
Safety of treatment regimens containing bedaquiline and delamanid in the endTB cohort.
Référence de l'article:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Jan 13; doi: 10.1093/cid/ciac019. Epub 2022 01 13
Higher risk sexual behaviour is associated with unawareness of HIV-positivity and lack of viral suppression - implications for Treatment as Prevention.
Référence de l'article:
Scientific reports 2017 Nov 23; 7(1); 16117. doi: 10.1038/s41598-017-16382-6. Epub 2017 11 23
Population-level HIV incidence estimates using a combination of synthetic cohort and recency biomarker approaches in KwaZulu-Natal, South Africa.
Référence de l'article:
PloS one 2018 ; 13(9); e0203638. doi: 10.1371/journal.pone.0203638. Epub 2018 09 13
Integrating hepatitis C treatment into multidrug-resistant TB care.
Référence de l'article:
Public health action 2022 Jun 21; 12(2); . doi: 10.5588/pha.22.0002. Epub 2022 06 23
Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.
Référence de l'article:
PloS one 2017 ; 12(1); e0170976. doi: 10.1371/journal.pone.0170976. Epub 2017 01 26
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens.
Référence de l'article:
BMC infectious diseases 2019 Aug 20; 19(1); 733. doi: 10.1186/s12879-019-4378-4. Epub 2019 08 20
Prevalence of TB and health-seeking behaviour.
Référence de l'article:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2022 May 01; 26(5); . doi: 10.5588/ijtld.22.0001. Epub 2022 05 05
Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis.
Référence de l'article:
PloS one 2020 ; 15(1); e0227138. doi: 10.1371/journal.pone.0227138. Epub 2020 01 30
Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey.
Référence de l'article:
BMC public health 2018 03 02; 18(1); 303. doi: 10.1186/s12889-018-5208-0. Epub 2018 03 02
Urine lipoarabinomannan (LAM) testing for all HIV patients hospitalized in the medical wards identifies a large proportion of patients with tuberculosis at risk of death.
Référence de l'article:
Open Forum Infectious Diseases; ofaa639; https://doi.org/10.1093/ofid/ofaa639; 23 December 2020
High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study.
Référence de l'article:
Archives of disease in childhood 2018 Dec 06; doi: 10.1136/archdischild-2018-315411. Epub 2018 12 06
Feasibility and acceptability of using the novel urine-based FujiLAM test to detect tuberculosis: A multi-country mixed-methods study.
Référence de l'article:
Journal of clinical tuberculosis and other mycobacterial diseases 2022 May ; 27; . doi: 10.1016/j.jctube.2022.100316. Epub 2022 04 25
Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings.
Référence de l'article:
Journal of acquired immune deficiency syndromes (1999) 2016 Apr 01; 71(4); e89-95. doi: 10.1097/QAI.0000000000000895. Epub 2016 07 06
Mortality in the first six months among HIV-positive and HIV-negative patients empirically treated for tuberculosis.
Référence de l'article:
BMC infectious diseases 2019 Feb 11; 19(1); 132. doi: 10.1186/s12879-019-3775-z. Epub 2019 02 11
Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients.
Référence de l'article:
The American journal of tropical medicine and hygiene 2020 Jan 20; doi: 10.4269/ajtmh.19-0493. Epub 2020 01 20
A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
Référence de l'article:
BMC infectious diseases 2017 09 29; 17(1); 653. doi: 10.1186/s12879-017-2740-y. Epub 2017 09 29
Two-fold increase in the HIV viral load suppression rate along with decreased incidence over six years in Ndhiwa sub-county, Kenya.
Référence de l'article:
Tropical medicine & international health : TM & IH 2021 Oct 12; doi: 10.1111/tmi.13688. Epub 2021 10 12
HIV epidemic and cascade of care in 12 east African rural fishing communities: results from a population-based survey in Uganda.
Référence de l'article:
BMC public health 2020 Jun 19; 20(1); 970. doi: 10.1186/s12889-020-09121-6. Epub 2020 06 19
Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
Référence de l'article:
PLoS medicine 2019 Apr ; 16(4); e1002792. doi: 10.1371/journal.pmed.1002792. Epub 2019 04 30
Evaluation of a Lung Ultrasound Score in Hospitalized Adult Patients with COVID-19 in Barcelona, Spain.
Référence de l'article:
Journal of clinical medicine 2024 Jun 02; 13(11); . doi: 10.3390/jcm13113282. Epub 2024 06 02
Experiences and perceptions of urine sampling for tuberculosis testing among HIV patients: a multisite qualitative descriptive study.
Référence de l'article:
BMJ open 2023 Nov 30; 13(11); . doi: 10.1136/bmjopen-2021-058805. Epub 2023 11 30
Feasibility of using Determine TB-LAM to diagnose tuberculosis in HIV-positive patients in programmatic conditions: a multisite study.
Référence de l'article:
Global health action 2019 ; 12(1); 1672366. doi: 10.1080/16549716.2019.1672366. Epub 2019 10 15
Is 6 months of bedaquiline enough? Results from the compassionate use of bedaquiline in Armenia and Georgia.
Référence de l'article:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2018 Jul 01; 22(7); 766-772. doi: 10.5588/ijtld.17.0840. Epub 2018 06 19
Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study.
Référence de l'article:
The Lancet. Global health 2023 Jan ; 11(1); . doi: 10.1016/S2214-109X(22)00463-6. Epub 2022 12 19
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications.
Référence de l'article:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2023 Jun 01; 27(6); . doi: 10.5588/ijtld.22.0613. Epub 2023 05 29
Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting.
Référence de l'article:
PloS one 2012 ; 7(12); e51336. doi: 10.1371/journal.pone.0051336. Epub 2012 12 19
Should Urine-LAM Tests Be Used in TB Symptomatic HIV-Positive Patients When No CD4 Count Is Available? A Prospective Observational Cohort Study From Malawi.
Référence de l'article:
Journal of acquired immune deficiency syndromes (1999) 2020 01 01; 83(1); 24-30. doi: 10.1097/QAI.0000000000002206. Epub 2020 07 06